Literature DB >> 9037478

Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment.

D E Selley1, E J Nestler, C S Breivogel, S R Childers.   

Abstract

The nucleus locus coeruleus is involved in the expression of opiate physical dependence and withdrawal, and has been characterized extensively with regard to chronic morphine-induced alterations in biochemical and electrophysiological responses. In the present study the effects of chronic morphine treatment on opioid receptor-coupled G-protein activity was investigated in membranes from rat locus coeruleus. Opioid agonists stimulated low Km GTPase activity with pharmacology consistent with mu receptors. Chronic morphine treatment resulted in decreases in both basal and opioid-stimulated low Km GTPase activity, with no change in the percent stimulation by agonist. The decrease in low Km GTPase activity appeared to be due to a decrease in the Vmax of the enzyme, with no change in the Km for GTP hydrolysis. These results were confirmed by assays of basal and opioid receptor-stimulated [35S]GTP gamma S binding in the presence of excess GDP. Thus, chronic morphine treatment apparently decreased inhibitory G-protein activity in the locus coeruleus without producing any detectable desensitization. These results suggest a potential adaptation at the receptor/transducer level which may contribute to other biochemical changes produced in the locus coeruleus by chronic morphine treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9037478     DOI: 10.1016/s0006-8993(96)01125-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Chronic baclofen desensitizes GABA(B)-mediated G-protein activation and stimulates phosphorylation of kinases in mesocorticolimbic rat brain.

Authors:  Bradley M T Keegan; Thomas J R Beveridge; Jeffrey J Pezor; Ruoyu Xiao; Tammy Sexton; Steven R Childers; Allyn C Howlett
Journal:  Neuropharmacology       Date:  2015-02-25       Impact factor: 5.250

2.  Shadows across mu-Star? Constitutively active mu-opioid receptors revisited.

Authors:  Mark Connor
Journal:  Br J Pharmacol       Date:  2009-04       Impact factor: 8.739

Review 3.  A review on neuroimaging studies of genetic and environmental influences on early brain development.

Authors:  Wei Gao; Karen Grewen; Rebecca C Knickmeyer; Anqi Qiu; Andrew Salzwedel; Weili Lin; John H Gilmore
Journal:  Neuroimage       Date:  2018-04-16       Impact factor: 6.556

Review 4.  Activators of G-protein signaling 3: a drug addiction molecular gateway.

Authors:  Michael Scott Bowers
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

5.  Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain.

Authors:  L J Sim-Selley; D E Selley; L J Vogt; S R Childers; T J Martin
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

6.  Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.

Authors:  L J Sim; R E Hampson; S A Deadwyler; S R Childers
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

Review 7.  Alterations in the levels of heterotrimeric G protein subunits induced by psychostimulants, opiates, barbiturates, and ethanol: Implications for drug dependence, tolerance, and withdrawal.

Authors:  Nobue Kitanaka; Junichi Kitanaka; F Scott Hall; Tomohiro Tatsuta; Yoshio Morita; Motohiko Takemura; Xiao-Bing Wang; George R Uhl
Journal:  Synapse       Date:  2008-09       Impact factor: 2.562

8.  Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence.

Authors:  Joseph A Kim; Selena Bartlett; Li He; Carsten K Nielsen; Amy M Chang; Viktor Kharazia; Maria Waldhoer; Chrissi J Ou; Stacy Taylor; Madeline Ferwerda; Dragana Cado; Jennifer L Whistler
Journal:  Curr Biol       Date:  2008-01-22       Impact factor: 10.834

9.  The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.

Authors:  Jenny L Wilkerson; Micah J Niphakis; Travis W Grim; Mohammed A Mustafa; Rehab A Abdullah; Justin L Poklis; William L Dewey; Hamid Akbarali; Matthew L Banks; Laura E Wise; Benjamin F Cravatt; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2016-01-20       Impact factor: 4.030

10.  Role of the guanine nucleotide binding protein, Gαo, in the development of morphine tolerance and dependence.

Authors:  Jennifer T Lamberts; Lisa D Rosenthal; Emily M Jutkiewicz; John R Traynor
Journal:  Psychopharmacology (Berl)       Date:  2017-10-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.